.pf{position:relative;background-color:#fff;overflow:hidden;margin:0;border:0}.pc{position:absolute;border:0;padding:0;margin:0;top:0;left:0;width:100%;height:100%;overflow:hidden;display:block;transform-origin:0 0;-ms-transform-origin:0 0;-webkit-transform-origin:0 0}.bi{position:absolute;border:0;margin:0}.c{position:absolute;border:0;padding:0;margin:0;overflow:hidden;display:block}.t{position:absolute;white-space:pre;font-size:1px;transform-origin:0 100%;-ms-transform-origin:0 100%;-webkit-transform-origin:0 100%;unicode-bidi:bidi-override;-moz-font-feature-settings:"liga" 0}.t:after{content:''}.t:before{content:'';display:inline-block}.t span{position:relative;unicode-bidi:bidi-override}._{display:inline-block;color:transparent;z-index:-1}.pi{display:none}@media screen{.pf{margin:13px auto;box-shadow:1px 1px 3px 1px #333;border-collapse:separate}}.ff1{font-family:ff1;line-height:.938477;font-style:normal;font-weight:400;visibility:visible}.ff2{font-family:ff2;line-height:.938965;font-style:normal;font-weight:400;visibility:visible}.m0{transform:matrix(.320260,0,0,.320260,0,0);-ms-transform:matrix(.320260,0,0,.320260,0,0);-webkit-transform:matrix(.320260,0,0,.320260,0,0)}.ls0{letter-spacing:0}.sc0{text-shadow:-.015em 0 transparent,0 .015em transparent,.015em 0 transparent,0 -.015em transparent}@media screen and (-webkit-min-device-pixel-ratio:0){.sc0{-webkit-text-stroke:.015em transparent;text-shadow:none}}.ws0{word-spacing:0}._0{width:43.048437px}.fc1{color:transparent}.fc0{color:#000}.fs0{font-size:48.045131px}.y1f{bottom:-368.443083px}.y1e{bottom:-341.515916px}.y1d{bottom:-315.550434px}.y1c{bottom:-288.623267px}.y1b{bottom:-262.657785px}.y1a{bottom:-235.730619px}.y19{bottom:-208.803452px}.y18{bottom:-182.83797px}.y17{bottom:-155.910804px}.y16{bottom:-129.945321px}.y15{bottom:-103.018155px}.y14{bottom:-76.090988px}.y13{bottom:-50.125506px}.y12{bottom:-23.19834px}.y0{bottom:0}.y11{bottom:2.767142px}.y10{bottom:29.694309px}.yf{bottom:56.621475px}.ye{bottom:82.586958px}.yd{bottom:109.514124px}.yc{bottom:135.479606px}.yb{bottom:162.406773px}.ya{bottom:189.333939px}.y9{bottom:215.299421px}.y8{bottom:242.226588px}.y7{bottom:268.192070px}.y6{bottom:295.119237px}.y5{bottom:322.046403px}.y4{bottom:348.011885px}.y3{bottom:374.939052px}.y2{bottom:400.904534px}.y1{bottom:507.293741px}.h3{height:34.978169px}.h4{height:35.001628px}.h2{height:507.295022px}.h1{height:1014.58492px}.h0{height:1014.588763px}.w1{width:783.997438px}.w0{width:784px}.x0{left:0}.x1{left:91.953969px}.x2{left:115.034397px}.x5{left:138.114826px}.x3{left:161.195254px}.x4{left:184.275683px}

IMED3001 Study Guide - Final Guide: Monocyte, Hemodynamics, Dyslipidemia

Australia

Body Systems and Disease I

Integrated Medical Sciences

Marcus Dabner

University of Western Australia

Human Biology II: Being Human

Physiology of Human Body Systems

Organisational Behaviour

The Musculoskeletal System and Movement

Applied Anatomy and Athletic Performance

Exercise Physiology

Psychosocial Aspects of Sport, Exercise and Health

Promoting Lifelong Physical Activity

Exercise Prescription and Nutrition for Health and Fitness

Lifespan Motor Development

Psychology of Sport

Form and Function

The Facts of Life

Cell Survival and Communication

Health and Society

Body Defences

Blood and Drugs

Essentials of Research in the Health and Medical Sciences

Human Development and Genetics

Body Systems and Disease II

Body Systems and Disease III

Body Systems and Disease IV

Science Work Placement

IMED3001 Lecture Notes - Lecture 9: Dyslipidemia, Hyperlipidemia, Thrombophilia

ADMS 3502 Lecture Notes - Lecture 34: Cholesteryl Ester, Cell Adhesion Molecule, Fibrous Cap

BPK 458 Lecture Notes - Lecture 1: Relative Risk Reduction, Genetic Linkage, Proteomics

IMED3001 Study Guide - Final Guide: Monocyte, Hemodynamics, Dyslipidemia

Get access

Related Documents

IMED3001 Lecture Notes - Lecture 9: Dyslipidemia, Hyperlipidemia, Thrombophilia

ADMS 3502 Lecture Notes - Lecture 34: Cholesteryl Ester, Cell Adhesion Molecule, Fibrous Cap

BPK 458 Lecture Notes - Lecture 1: Relative Risk Reduction, Genetic Linkage, Proteomics